Literature DB >> 33171520

The East Asian Paradox: An Updated Position Statement on the Challenges to the Current Antithrombotic Strategy in Patients with Cardiovascular Disease.

Hyun Kuk Kim1, Udaya S Tantry2, Sidney C Smith3, Myung Ho Jeong4, Seung-Jung Park5, Moo Hyun Kim6, Do-Sun Lim7, Eun-Seok Shin8, Duk-Woo Park5, Yong Huo9, Shao-Liang Chen10, Zheng Bo9, Shinya Goto11, Takeshi Kimura12, Satoshi Yasuda13, Wen-Jone Chen14, Mark Chan15, Daniel Aradi16, Tobias Geisler17, Diana A Gorog18,19, Dirk Sibbing20,21, Gregory Y H Lip22, Dominick J Angiolillo23, Paul A Gurbel2, Young-Hoon Jeong24,25.   

Abstract

East Asian patients have reduced anti-ischemic benefits and increased bleeding risk during antithrombotic therapies compared with Caucasian patients. As potent P2Y12 receptor inhibitors (e.g., ticagrelor and prasugrel) and direct oral anticoagulants are commonly used in current daily practice, the unique risk-benefit trade-off in East Asians has been a topic of emerging interest. In this article, we propose updated evidence and future directions of antithrombotic treatment in East Asian patients. Thieme. All rights reserved.

Entities:  

Year:  2020        PMID： 33171520     DOI： 10.1055/s-0040-1718729

Source DB:  PubMed          Journal:  Thromb Haemost        ISSN： 0340-6245            Impact factor:   5.249


  20 in total

Review 1.  P2Y12 inhibitor monotherapy in patients undergoing percutaneous coronary intervention.

Authors:  Davide Capodanno; Usman Baber; Deepak L Bhatt; Jean-Philippe Collet; George Dangas; Francesco Franchi; C Michael Gibson; Hyeon-Cheol Gwon; Adnan Kastrati; Takeshi Kimura; Pedro A Lemos; Renato D Lopes; Roxana Mehran; Michelle L O'Donoghue; Sunil V Rao; Fabiana Rollini; Patrick W Serruys; Philippe G Steg; Robert F Storey; Marco Valgimigli; Pascal Vranckx; Hirotoshi Watanabe; Stephan Windecker; Dominick J Angiolillo
Journal:  Nat Rev Cardiol       Date:  2022-06-13       Impact factor: 32.419

2.  Utility of a pharmacogenetic-driven algorithm in guiding dual antiplatelet therapy for patients undergoing coronary drug-eluting stent implantation in China.

Authors:  Si-Qi Lyu; Jun Zhu; Juan Wang; Shuang Wu; Han Zhang; Xing-Hui Shao; Yan-Min Yang
Journal:  Eur J Clin Pharmacol       Date:  2021-10-12       Impact factor: 2.953

3.  The association between prothrombin time-international normalized ratio and long-term mortality in patients with coronary artery disease: a large cohort retrospective study with 44,662 patients.

Authors:  Liwei Liu; Ming Ying; Shiqun Chen; Qiang Li; Guanzhong Chen; Huanqiang Li; Ziling Mai; Yibo He; Bo Wang; Danyuan Xu; Zhidong Huang; Xiaoming Yan; Ning Tan; Zhujun Chen; Jin Liu; Yong Liu
Journal:  BMC Cardiovasc Disord       Date:  2022-06-29       Impact factor: 2.174

4.  Beginning the Journey to Find Optimal Antithrombotic Regimens for Korean Patients with Atrial Fibrillation after Percutaneous Coronary Intervention.

Authors:  Sung Soo Kim; Hyun Kuk Kim
Journal:  Korean Circ J       Date:  2021-03-05       Impact factor: 3.243

5.  Impact of Non-Vitamin K Antagonist Oral Anticoagulants on the Change of Antithrombotic Regimens in Patients with Atrial Fibrillation Undergoing Percutaneous Coronary Intervention.

Authors:  Soonil Kwon; Jin Hyung Jung; Eue Keun Choi; Seung Woo Lee; Jiesuck Park; So Ryoung Lee; Jeehoon Kang; Kyungdo Han; Kyung Woo Park; Seil Oh; Gregory Y H Lip
Journal:  Korean Circ J       Date:  2021-01-25       Impact factor: 3.243

Review 6.  Platelet Function and Genotype after DES Implantation in East Asian Patients: Rationale and Characteristics of the PTRG-DES Consortium.

Authors:  Ae-Young Her; Young-Hoon Jeong; Byeong-Keuk Kim; Hyung Joon Joo; Kiyuk Chang; Yongwhi Park; Young Bin Song; Sung Gyun Ahn; Jung-Won Suh; Sang Yeup Lee; Jung Rae Cho; Hyo-Soo Kim; Moo Hyun Kim; Do-Sun Lim; Eun-Seok Shin
Journal:  Yonsei Med J       Date:  2022-05       Impact factor: 3.052

7.  2021 Focused Update Consensus Guidelines of the Asia Pacific Heart Rhythm Society on Stroke Prevention in Atrial Fibrillation: Executive Summary.

Authors:  Tze-Fan Chao; Boyoung Joung; Yoshihide Takahashi; Toon Wei Lim; Eue-Keun Choi; Yi-Hsin Chan; Yutao Guo; Charn Sriratanasathavorn; Seil Oh; Ken Okumura; Gregory Y H Lip
Journal:  Thromb Haemost       Date:  2021-11-13       Impact factor: 5.249

8.  Comparison of early clinical outcomes between dual antiplatelet therapy and triple antithrombotic therapy in patients with atrial fibrillation undergoing percutaneous coronary intervention.

Authors:  Jiesuck Park; Jin-Hyung Jung; Eue-Keun Choi; Seung-Woo Lee; Soonil Kwon; So-Ryoung Lee; Jeehoon Kang; Kyung-Do Han; Kyung Woo Park; Seil Oh; Gregory Y H Lip
Journal:  PLoS One       Date:  2022-02-25       Impact factor: 3.240

9.  Clinical Characteristics and Long-Term Outcomes of Patients With Differing Haemoglobin Levels Undergoing Semi-Urgent and Elective Percutaneous Coronary Intervention in an Asian Population.

Authors:  Rodney Yu-Hang Soh; Ching-Hui Sia; Andie Hartanto Djohan; Rui-Huai Lau; Pei-Ying Ho; Jonathan Wen-Hui Neo; Jamie Sin-Ying Ho; Hui-Wen Sim; Tiong-Cheng Yeo; Huay-Cheem Tan; Mark Yan-Yee Chan; Joshua Ping-Yun Loh
Journal:  Front Cardiovasc Med       Date:  2022-03-18

10.  Clinical Outcomes of Ticagrelor in Korean Patients with Acute Myocardial Infarction without High Bleeding Risk.

Authors:  Keun-Ho Park; Myung Ho Jeong; Hyun Kuk Kim; Young-Jae Ki; Sung Soo Kim; Dong-Hyun Choi; Young-Youp Koh; Youngkeun Ahn; Hyo-Soo Kim; Hyeon-Cheol Gwon; Seung-Woon Rha; Jin-Yong Hwang
Journal:  J Korean Med Sci       Date:  2021-11-01       Impact factor: 2.153
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.